OSL:VISTN - Euronext Oslo - NO0010734122 - Common Stock - Currency: NOK
OSL:VISTN (4/25/2025, 7:00:00 PM)
24
+0.4 (+1.69%)
The current stock price of VISTN.OL is 24 NOK. In the past month the price decreased by -2.83%. In the past year, price increased by 0.42%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY.DE | ELI LILLY & CO | 66.57 | 722.56B | ||
1LLY.MI | ELI LILLY & CO | 65.28 | 708.62B | ||
ZEG.DE | ASTRAZENECA PLC | 16.86 | 377.93B | ||
JNJ.DE | JOHNSON & JOHNSON | 15.24 | 324.94B | ||
NOV.DE | NOVO NORDISK A/S-B | 17.94 | 241.31B | ||
1SAN.MI | SANOFI | 12.19 | 229.14B | ||
SNW.DE | SANOFI | 13.77 | 226.94B | ||
SAN.PA | SANOFI | 13.72 | 226.10B | ||
6MK.DE | MERCK & CO. INC. | 10.13 | 174.89B | ||
1MRKX.MI | MERCK & CO. INC. | 9.96 | 171.87B | ||
PFE.DE | PFIZER INC | 7.33 | 113.97B | ||
1PFE.MI | PFIZER INC | 7.14 | 111.02B |
Vistin Pharma ASA is a pharmaceutical company, which engages in the production of Metformin Active Pharmaceutical Ingredients (API). The company is headquartered in Oslo, Oslo. The company went IPO on 2015-06-10. The firm is engaged in the pharmaceuticals industry. The firm is a producer and supplier of Active Pharmaceutical Ingredients (APIs), which are used in medications for diabetes. Vistin Pharma offering such products: Metformin HCl (API); Metformin DC (direct compressible granules); Customized Particle Distribution (PSD) and Premix (Metformin + MgSt, can be delivered on-request). The Company’s customers are pharmaceutical companies worldwide.
VISTIN PHARMA ASA
Ostensjoveien 27
Oslo OSLO NO
Employees: 75
Company Website: https://www.vistin.com/
Investor Relations: http://www.vistin.com/investors/category455.html
Phone: 4748926506
The current stock price of VISTN.OL is 24 NOK. The price increased by 1.69% in the last trading session.
The exchange symbol of VISTIN PHARMA ASA is VISTN and it is listed on the Euronext Oslo exchange.
VISTN.OL stock is listed on the Euronext Oslo exchange.
VISTIN PHARMA ASA (VISTN.OL) has a market capitalization of 1.06B NOK. This makes VISTN.OL a Small Cap stock.
VISTIN PHARMA ASA (VISTN.OL) currently has 75 employees.
VISTIN PHARMA ASA (VISTN.OL) has a support level at 23.92 and a resistance level at 24.1. Check the full technical report for a detailed analysis of VISTN.OL support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
VISTIN PHARMA ASA (VISTN.OL) has a dividend yield of 5.3%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of VISTN.OL dividend history, reliability and sustainability.
VISTIN PHARMA ASA (VISTN.OL) will report earnings on 2025-08-21.
The PE ratio for VISTIN PHARMA ASA (VISTN.OL) is 17.02. This is based on the reported non-GAAP earnings per share of 1.41 and the current share price of 24 NOK. Check the full fundamental report for a full analysis of the valuation metrics for VISTN.OL.
ChartMill assigns a technical rating of 3 / 10 to VISTN.OL. When comparing the yearly performance of all stocks, VISTN.OL turns out to be only a medium performer in the overall market: it outperformed 57.14% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to VISTN.OL. VISTN.OL is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
Over the last trailing twelve months VISTN.OL reported a non-GAAP Earnings per Share(EPS) of 1.41. The EPS increased by 37.32% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 14.49% | ||
ROA | 15.82% | ||
ROE | 19.75% | ||
Debt/Equity | 0.02 |
ChartMill assigns a Buy % Consensus number of 40% to VISTN.OL. The Buy consensus is the average rating of analysts ratings from 7 analysts.